KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 18 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,264,731 | -9.2% | 25,000,000 | 0.0% | 0.24% | -31.2% |
Q2 2023 | $16,812,500 | -12.7% | 25,000,000 | 0.0% | 0.35% | +7.6% |
Q1 2023 | $19,256,425 | +102072.4% | 25,000,000 | 0.0% | 0.33% | +16250.0% |
Q4 2022 | $18,847 | -99.9% | 25,000,000 | 0.0% | 0.00% | -99.5% |
Q3 2022 | $19,953,000 | +10.0% | 25,000,000 | 0.0% | 0.37% | +16.6% |
Q2 2022 | $18,139,000 | -13.3% | 25,000,000 | 0.0% | 0.31% | +16.7% |
Q1 2022 | $20,932,000 | +3.7% | 25,000,000 | 0.0% | 0.27% | -9.4% |
Q4 2021 | $20,188,000 | +17.4% | 25,000,000 | +8.7% | 0.30% | +20.7% |
Q3 2021 | $17,194,000 | -13.9% | 23,000,000 | +15.0% | 0.25% | +58.7% |
Q2 2021 | $19,960,000 | -2.3% | 20,000,000 | 0.0% | 0.16% | -23.6% |
Q1 2021 | $20,429,000 | -17.9% | 20,000,000 | 0.0% | 0.20% | -30.5% |
Q4 2020 | $24,888,000 | +49.9% | 20,000,000 | +42.9% | 0.29% | +23.7% |
Q3 2020 | $16,600,000 | -15.1% | 14,000,000 | 0.0% | 0.24% | -50.0% |
Q2 2020 | $19,551,000 | -1.5% | 14,000,000 | 0.0% | 0.47% | -10.9% |
Q1 2020 | $19,853,000 | -0.4% | 14,000,000 | 0.0% | 0.53% | +18.0% |
Q4 2019 | $19,941,000 | – | 14,000,000 | – | 0.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 9,000,000 | $6,561,000 | 2.60% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,050,000 | $22,600,000 | 0.52% |
Context Capital Management, LLC | 7,000 | $5,079,000 | 0.36% |
DeepCurrents Investment Group LLC | 11,890,000 | $8,569,000 | 0.34% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $18,139,000 | 0.31% |
CAPSTONE INVESTMENT ADVISORS, LLC | 5,500,000 | $4,046,000 | 0.02% |
LAZARD ASSET MANAGEMENT LLC | 17,500,000 | $12,872,000 | 0.02% |
BLB&B Advisors, LLC | 100,000 | $73,000 | 0.01% |
MACKAY SHIELDS LLC | 221,000 | $163,000 | 0.00% |
JPMORGAN CHASE & CO | 900,000 | $655,000 | 0.00% |